Pharmaceuticals in MN Begin Price Negotiation Program
danbrookens2023-08-30T07:15:31-05:00Yesterday, the US Department of Health and Human Services (HHS) announced the first 10 drugs to participate in the new Medicare Drug Price Negotiation program. This program, part of the Inflation Reduction Act, allows Medicare to negotiate lower prices for prescription drugs. Senator Amy Klobuchar (D - Minnesota) commented on the announcement, saying more are on the way. The ten drugs chosen to start the negotiation process are Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara, Fiasp; Fiasp FlexTouch; Fiasp PenFill; NovoLog; NovoLog FlexPen; and NovoLog PenFill. According to HHS, these drugs cost Medicare recipients a total of [...]